The Nasdaq reaching new heights, as the index surpasses 20,000 for the first time ever. The tech surge that brought it there, and if the rally has more room to run. Plus Nuclear energy taking off, as power hungry AI data centers drive fuel demand. An inside look at one uranium mine in Canada that’s 1600 feet underground.

Fast Money Disclaimer

Shares of Alphabet surging as Google unveils a ‘breakthrough’ quantum computing chip. What it means for the future of coding, and the areas of tech that could benefit. Plus A spotlight on the health insurance space, as the suspect in the UNH CEO murder investigation heads to his first court appearance. The latest details on his motives, and how it could all impact other players in the health insurance space.

Fast Money Disclaimer

Some of this year’s hottest stocks staging a major reversal to start the week. The Tech, restaurants, and asset manager stocks in the red, and if there’s more pain to come. Plus Major developments in the UnitedHealthcare CEO’s murder investigation, and the slaying has the whole insurance space under a spotlight. How AI may be behind a slew of claim denials… and what it means for the future of the industry.

Fast Money Disclaimer

Social stocks gaining momentum as an appeals court upholds the law requiring a ban or sale of TikTok. What it means for the likes of Meta and Snap… and when the social media platform could get blocked. Plus UNH notches its worst week since before the pandemic. The fallout from the company’s CEO’s murder… and how the company will move forward from here.

Fast Money Disclaimer

All eyes on tomorrow’s November jobs report, as stocks take a breather from their recent rally. The pockets of strength in today’s trading, and what tomorrow’s employment data could mean for the markets next move. Plus Bitcion finally breaking through the elusive $100,000 level. What the milestone means for the crypto space, and where retail investors are putting their money to work.

Fast Money Disclaimer

Big tech taking the lead, and driving the S&P 500 and Nasdaq to fresh record highs. How semis, software, and other sections of the tech trade can fuel your portfolio. Plus Fast Money’s Obesity Week coverage continues. Eli Lilly’s Chief Scientific Officer breaks down how the company’s obesity drug Zepbound performed in its first head-to-head clinical trial against Novo’s Wegovy, and what the results could mean for the weight loss drug wars.

Fast Money Disclaimer

Tariff threats and trade restrictions are the latest irritations in rising U.S/China tensions. But the Chartmaster Carter Worth says now could be the time to get in. What he’s seeing in the technicals, and how your money can fare in the China trade. Plus Fast Money’s special coverage of the weight loss drug space continues. How one biotech company is standing out from the competition, and how its obesity drug could do more than trim your waistline.

Fast Money Disclaimer

Intel CEO Pat Gelsinger stepping down, as the chipmaker looks to bounce back from a tumultuous couple of years. What the turnaround plans may look like now, and how Intel can keep up with competition. Plus Fast Money’s Obesity Week kicks off. The emerging players in the weight-loss drug battle, and what industry leaders see next for the space.

Fast Money Disclaimer

A check on the health of the consumer, as buyers gear up for Black Friday shopping. How gas prices, inflation, and mortgage rates are helping paint the picture for what to expect out of retailers this season. And will stocks keep powering higher into year end? The bullish case for equities to keep charging, and where there’s still opportunity in the market.

Fast Money Disclaimer

Listen to our traders take you behind the money...how to play the volatility...pops and drops and the movers you missed.

Fast Money Disclaimer